.webp&w=3840&q=75)

The Experimental and Translational Immunology program at University College London (UCL) is a one-year, full-time Master of Research (MRes) degree that focuses on the advanced study of immunology, with an emphasis on the experimental and translational aspects of the field. This program is designed for students who wish to delve into the mechanisms of immune system function and its role in diseases, as well as the development of immune-based therapies. Students will engage in cutting-edge research, learning how to translate laboratory findings into clinical applications to improve disease prevention, diagnosis, and treatment.
UCL’s Experimental and Translational Immunology program combines experimental immunology with the latest advances in translational science. Graduates will be well-equipped to pursue careers in immunology research, biotechnology, or the pharmaceutical industry, contributing to the development of immune-based therapies for various diseases, including cancer, autoimmune disorders, and infections.
The Experimental and Translational Immunology program is structured around core modules in immunological techniques, disease pathogenesis, and the principles of translational research. Students will gain hands-on experience in experimental immunology, including laboratory research, data analysis, and the use of advanced techniques such as flow cytometry and molecular biology. The program also includes a research project where students will conduct original research, applying experimental findings to real-world clinical scenarios. The program culminates in a dissertation, allowing students to explore a specific area of immunology in depth.
Graduates of the MRes in Experimental and Translational Immunology program will be well-prepared for careers in academic research, biotechnology, and the pharmaceutical industry. Career opportunities include roles in immunology research, clinical trials, and the development of immune-based therapies. Graduates can also work in regulatory affairs, health policy, or clinical development, helping to bring innovative immunological treatments to market. The program provides a strong foundation for those wishing to pursue further studies in PhD programs or in the biomedical research sector.
UCL’s Experimental and Translational Immunology program stands out for its combination of cutting-edge research and practical applications in immunology. Students will benefit from access to UCL’s state-of-the-art facilities and its strong links with leading research institutions and pharmaceutical companies. The program provides a unique opportunity to engage in translational research that bridges the gap between laboratory discoveries and clinical applications, preparing students to contribute to the development of new immune-based therapies.
For further information, please contact the admissions office at:
Phone: +44 (0)20 7679 2000
Email: contact@ucl.ac.uk
Address: University College London, Gower Street, London WC1E 6BT, United Kingdom